Investment Holding Companies

VSEE HEALTH INC C/WTS (TO PUR COM)

VSee Health Inc. and DocBox Collaborate to Launch AI-Powered Virtual ICU Platform

Freecast

Cuprina

U-BX Tech

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Defiance Pure Space Dly 2X Strat ETF

VS MEDIA

Everbright Digital

Park Ha Biological Tech

Friedman Industries

Defiance Daily Target 2X Short ASTS ETF

VSEE

VSEEW

VSee Health secured $271,739.13 in private debt financing via an 8% OID secured promissory note bearing 18% annual interest, maturing Dec 8, 2026. The deal requires repayment upon equity line proceeds and includes a prepayment option. Spark AI rates VSEE stock as Neutral due to weak financials, cash burn, bearish technicals, and dilution risks from equity issuance.

Tip Ranks

VSee Health

VSee Health Secures New Private Debt Financing Agreement

Earnings Watch

VSEE HEALTH INC C/WTS (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 3.16 M

VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet | VSEE Stock News

StockTitan

iShares Global Healthcare

iShares US Healthcare Providers

SPDR S&P Health

Health Care Select Sector SPDR

VG Health

VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet | VSEE Stock News

AIFF

In Monday's pre-market session, several health care stocks saw significant movement. Milestone Scientific (MLSS) shares surged 34.4% to $0.33, while BGM Group (BGM) rose 30.44% to $0.78. Zhengye Biotechnology (ZYBT) increased by 26.76% to $0.9, and Firefly Neuroscience (AIFF) gained 23.52% to $1.89. Apogee Therapeutics (APGE) and Insmed (INSM) also saw increases of 13.56% and 10.25%, respectively. Conversely, Valneva (VALN) dropped 36.8% to $6.52, followed by Impact BioMedical (IBO) down 23.04% to $0.6. Other notable losers included Onconetix (ONCO), Anika Therapeutics (ANIK), NeuroPace (NPCE), and CDT Equity (CDT).

benzinga_article

Invesco Dorsey Wright Healthcare Momentum ETF

VanEck Biotech ETF

Firefly Neuroscience

Milestone Scientific

Apogee Therapeutic

Proshares Ultra Nasdaq Biotech

Insmed

Zhengye Biotechnology

Invesco Biotechnology & Genome ETF

Onconetix

iShares US Medical Devices

First Trust NYSE Arca Biotech Index Fd

iShares US Pharma

SPDR S&P Health Equip

12 Health Care Stocks Moving In Monday's Pre-Market Session

Oneview Healthcare Raises A$19m in Upsized Placement and Launches SPP to Fund AI and Growth

Viemed Healthcare

Oneview Healthcare PLC Chess Depository Interests repr 1

BlackRock, Inc.

Oneview Healthcare Raises A$19m in Upsized Placement and Launches SPP to Fund AI and Growth

SBIO

ARKG

In Wednesday's pre-market session, several health care stocks experienced significant movements. Gainers included Kala Bio (up 63.3% to $0.48), SCWorx (up 20.37% to $0.15), Auna (up 18.77% to $5.7), SS Innovations (up 17.19% to $5.18), Acurx Pharmaceuticals (up 14.13% to $3.31), and Damora Therapeutics (up 14.07% to $29.1). Conversely, losers included Skye Bioscience (down 18.6% to $0.65), MiNK Therapeutics (down 15.77% to $11.38), Pomdoctor (down 13.16% to $0.28), Cuprina Holdings (down 12.95% to $0.32), and Verrica Pharmaceuticals (down 12.21% to $5.25).

ALPS Medical Breakthrough

Pomdoctor

SCWorx

iShares Biotechnology ETF

SPDR S&P Biotech

Skye Bioscience

SS Innovations

Acurx Pharmaceuticals

Verrica Pharmaceuticals

MiNK Therapeutics

Invesco Nasdaq Biotechnology ETF

Ark Genomic Revolution ETF

KALA BIO

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

VSee has launched the world's first autonomous telehealth AI robot at HIMSS 2026, designed to navigate directly to patients' bedsides without staff assistance. This innovation aims to enhance healthcare delivery by enabling remote clinicians to conduct virtual rounds, respond to emergencies, and deliver medications efficiently. The robot utilizes advanced navigation technology and integrates with VSee's AI Workflow Engine, allowing hospitals to deploy clinical AI capabilities without extensive IT overhauls. The VSee AI Robot promises immediate ROI by optimizing staff utilization and expanding specialist services without increasing headcount.

VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026 | VSEE Stock News

VSEE Health Inc. has partnered with GoMyRx to enhance telehealth services by integrating prescription fulfillment and medication delivery. This strategic partnership aims to improve digital healthcare delivery across the U.S. GoMyRx will act as VSEE's primary operational partner, facilitating prescription workflows and direct-to-patient services. The collaboration connects VSEE's telehealth infrastructure with GoMyRx's fulfillment operations, promoting access to personalized healthcare. VSEE stock is currently trading at $0.37 in premarket.

EXCLUSIVE: Penny Stock VSEE Health Teams Up With GoMyRx To Expand Telehealth Drug Delivery

VSEE HEALTH INC C/WTS (TO PUR COM)(VSEEW.US)

VSee Health Secures New Private Debt Financing Agreement

VSEE HEALTH INC C/WTS (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 3.16 M

VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet | VSEE Stock News

12 Health Care Stocks Moving In Monday's Pre-Market Session

Oneview Healthcare Raises A$19m in Upsized Placement and Launches SPP to Fund AI and Growth